Extent of surgery for unilateral papillary thyroid cancer with nonsuspicious contralateral nodules by ultrasound

被引:0
|
作者
Xu, Siyuan [1 ]
Huang, Hui [2 ]
Xian, Keyao [2 ]
Wang, Xiaolei [2 ]
Xu, Zhengang [2 ]
Liu, Shaoyan [2 ]
Liu, Jie [2 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Minist Educ,Key Lab Otolaryngol Head & Neck Surg, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Dept Head & Neck Surg Oncol,Canc Hosp, Beijing, Peoples R China
关键词
Papillary thyroid carcinoma; Nonsuspicious contralateral nodule; Lobectomy; Total thyroidectomy; Nodule enucleation; Prognosis; COMPLETION THYROIDECTOMY; RADIOACTIVE IODINE; NATURAL-HISTORY; LOW-RISK; CARCINOMA; MANAGEMENT; SURVIVAL;
D O I
10.1007/s12020-024-03850-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe discussion about surgical treatment of patients with papillary thyroid cancer(PTC) has been an ongoing issue, which is mainly focused on characteristics of tumor, but rarely on nonsuspicious contralateral nodules. We aimed to compare recurrence-free survival(RFS)/progression-free survival(PFS) of unilateral PTC patients with nonsuspicious contralateral nodules after different extents of surgery. MethodsUnilateral PTC patients with nonsuspicious contralateral nodules underwent surgery from 2015 to 2017 were enrolled. The association between surgical extent and RFS/PFS was analyzed by Kaplan-Meier method and Cox proportional hazards model. ResultsA total of 1293 PTC patients (595[46.0%]TT,523[40.4%]lobectomy+nodule enucleation(LNE),175[13.5%]lobectomy) were analyzed. Patients with a greater surgical extent were more likely to be older, have a greater multifocality of the tumor and contralateral nodules, larger contralateral nodules and primary tumors, and more micro extrathyroidal extension (P < 0.05). After a median follow-up of 45 months, significant growth(>3 mm) was identified in 24 (4.6%) and 19 (10.9%) patients in the LNE and lobectomy group, 7 (1.2%), 14 (2.7%) and 11 (6.3%) structural recurrences and 7 (1.2%), 11 (2.1%) and 7 (4.0%) progression in disease were identified in the TT, LNE and lobectomy groups, respectively. Unadjusted and adjusted RFS/PFS were significantly worse for patients treated with lobectomy than for those who underwent LNE or TT(3-year RFS, 95.5%, 98.2% vs. 99.0%; 3-year PFS, 97.9%, 98.9% vs. 99.0%, P < 0.05), but difference in PFS between LNE and TT lost statistical significance (unadjusted P = 0.226, adjusted P = 0.150). ConclusionsDue to subtle changes in nodules and acceptable prognosis, lobectomy is a considerable option for unilateral PTC patients with nonsuspicious nodules, when a similar prognosis to TT is expected, LNE may be an effective alternative to optimize quality of life.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 50 条
  • [31] Preoperative BRAF Mutation is Predictive of Occult Contralateral Carcinoma in Patients with Unilateral Papillary Thyroid Microcarcinoma
    Zhou, Yi-Li
    Zhang, Wei
    Gao, Er-Li
    Dai, Xuan-xuan
    Yang, Han
    Zhang, Xiao-Hua
    Wang, Ou-Chen
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (04) : 1267 - 1272
  • [32] Total thyroidectomy versus hemithyroidectomy with intraoperative radiofrequency ablation for unilateral thyroid cancer with contralateral nodules: A propensity score matching study
    Yuan, Qianqian
    Zheng, Lewei
    Hou, Jinxuan
    Zhou, Rui
    Xu, Gaoran
    Li, Chengxin
    Wu, Gaosong
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 51 (01):
  • [33] Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer
    Sullivan, Michael C.
    Graham, Paul H.
    Alexander, Erik K.
    Ruan, Daniel T.
    Nehs, Matthew A.
    Gawande, Atul A.
    Moore, Francis D., Jr.
    Howitt, Brooke E.
    Strickland, Kyle C.
    Krane, Jeffrey F.
    Barletta, Justine A.
    Cho, Nancy L.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 224 (06) : 1021 - 1027
  • [34] Machine learning algorithms for identifying contralateral central lymph node metastasis in unilateral cN0 papillary thyroid cancer
    Ren, Anwen
    Zhu, Jiaqing
    Wu, Zhenghao
    Ming, Jie
    Ruan, Shengnan
    Xu, Ming
    Huang, Tao
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [35] Completion Thyroidectomy in Patients Diagnosed with Papillary Thyroid Cancer: Is There a Predictive Factor for Contralateral Lobe Tumor?
    Kaya, Cemal
    Bozkurt, Emre
    Omeroglu, Sinan
    Mihmanli, Mehmet
    Uludag, Mehmet
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2018, 52 (04): : 262 - 267
  • [36] The Impact of the Extent of Surgery on the Long-Term Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis
    Bojoga, Andreea
    Koot, Anna
    Bonenkamp, Johannes
    de Wilt, Johannes
    IntHout, Joanna
    Stalmeier, Peep
    Hermens, Rosella
    Smit, Johannes
    Ottevanger, Petronella
    Netea-Maier, Romana
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07)
  • [37] Multifocality of the primary tumor is a predictive factor for contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma
    Gu, Jialei
    Nie, Xilin
    Wang, Wendong
    Xiang, Yangfeng
    Jiang, Lin
    Shang, Jinbiao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (11): : 11972 - 11977
  • [38] The extent of extrathyroidal extension is a key determinant of prognosis in T4a papillary thyroid cancer
    Abraham, Earl
    Roshan, David
    Tran, Bryan
    Wykes, James
    Campbell, Peter
    Ebrahimi, Ardalan
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (06) : 1016 - 1022
  • [39] Individualized optimal surgical extent of the lateral neck in papillary thyroid cancer with lateral cervical metastasis
    Park, Jae-Yong
    Koo, Bon Seok
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2014, 271 (06) : 1355 - 1360
  • [40] Anatomical Patterns of Nodal Spread in Unilateral Papillary and Medullary Thyroid Cancer
    Machens, Andreas
    Lorenz, Kerstin
    Weber, Frank
    Dralle, Henning
    THYROID, 2024, 34 (07) : 871 - 879